Patients hospitalized with inflammatory bowel disease (IBD) flares are at risk of chronic steroid use when they are discharged without a clear prednisone tapering plan (and steroid-sparing treatment strategy) or gastroenterology follow-up. Our quality improvement (QI) project examines the impact of a new hospital-wide 6-week standardized oral prednisone taper electronic order set.